People who were overweight or obese lost significant weight while taking retatrutide, which enabled them to be more active and reduced knee pain by an average of 4.5 points or about 76% based on pain scores from whats known as the Western Ontario and McMaster Universities Osteoarthritis Index
There were no cases of glucose intolerance, insulin resistance, edema (fluid retention), joint pain, carpal tunnel syndrome, or other manifestations of excess growth hormone activity
Topical application, the most common route of use, has demonstrated excellent safety with minimal adverse effects reported
FAQs: How is B12/MIC different from standard B12 injections
Skin & Immune Balance supports healthier skin and improved immune resilience
What purity is VivePeptides GHK-Cu